Changeflow GovPing Search

1 result for "National Research Institute of Chinese Medicine, Ministry of Health and Welfare"

• USPTO Patent Grants - Pharma (A61K)
Favicon for changeflow.com

Plant TCM Composition for COVID-19 Treatment

The USPTO granted patent US12605420B2 to the National Research Institute of Chinese Medicine, Ministry of Health and Welfare, covering a traditional Chinese medicine composition for treating COVID-19 symptoms. The composition comprises ten herbal ingredients including Prepared Monkshood Daughter Root, Scutellaria Root, and Heartleaf Houttuynia Herb. The patent contains 8 claims and is classified under CPC A61K 36/714.

Routine Rule Pharmaceuticals

Get alerts for "National Research Institute of Chinese Medicine, Ministry of Health and Welfare"

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

Filters

Browse Categories

Agriculture & Food Safety 73 AI Regulation 3 Banking & Finance 414 Consumer Protection 89 Courts & Legal 411 Data Privacy & Cybersecurity 90 Defense & National Security 53 Education 55 Energy 100 Environment 152 Gaming 2 Government & Legislation 431 Healthcare 15 Healthcare & Life Sciences 375 Immigration 10 Insurance 76 Labor & Employment 138 Pharma & Drug Safety 21 Professional Licensing 8 Real Estate & Housing 78 Securities & Markets 154 Tax 78 Telecom & Technology 47 Trade & Sanctions 141 Transportation 91

Get alerts for "National Research Institute of Chinese Medicine, Ministry of Health and Welfare"

We'll email you when new changes match "National Research Institute of Chinese Medicine, Ministry of Health and Welfare".

Free. Unsubscribe anytime.

You're subscribed!